QGENNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
QIAGEN N.V.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 20, 2026
$46.55+0.42 (+0.91%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 24.0
- Dividend yield
- 0.54%
Dividends
Dividend declared per share by fiscal year, adjusted for stock splits
Per share, FY2025
$0.25
Consecutive increases
0 years
Not raised last year
Dividend yield
0.54%
Latest annual dividend ÷ share price
Payout ratio, FY2025
12.8%
Dividends paid ÷ net income
Dividend history
By fiscal year
| Fiscal year | Per share | Change | Cash paid | Payout ratio |
|---|---|---|---|---|
| FY2025 | $0.25 | – | $54.24M | 12.8% |
Ex-dividend and payment dates for each distribution will appear once a dividend calendar source is connected.